Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study.
Saved in:
| Title: | Outcomes for single antiplatelet, dual antiplatelet, or oral anticoagulation after Amulet: Insights from EMERGE LAA post-approval study. |
|---|---|
| Authors: | Shah AP; The University of Chicago, Chicago, IL, United States of America. Electronic address: ashah@bsd.uchicago.edu., Freeman JV; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, United States of America., Alkhouli M; Mayo Clinic, Rochester, MN, United States of America., Agarwal H; CHI Creighton University School of Medicine - Bergan Mercy Hospital, Omaha, NE, United States of America., Coylewright M; Heart and Vascular Center, Essentia Health, Duluth, MN, United States of America., Makkar A; Arizona Heart Arrhythmia Associates, Phoenix, AZ, United States of America., Anderson J; Abbott Structural Heart, Plymouth, MN, United States of America., Gage R; Abbott Structural Heart, Plymouth, MN, United States of America., Freixa X; Hospital Clinic of Barcelona, Barcelona, Spain., Nielsen-Kudsk JE; Aarhus University Hospital, Aarhus N, Denmark., Lakkireddy D; Kansas City Heart Rhythm Institute and Research Foundation, Overland Park, KS, United States of America. |
| Source: | Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2026 May; Vol. 86, pp. 1-9. Date of Electronic Publication: 2025 Jul 25. |
| Publication Type: | Journal Article; Comparative Study; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101238551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0938 (Electronic) Linking ISSN: 18780938 NLM ISO Abbreviation: Cardiovasc Revasc Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
